Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2009
03/19/2009WO2009036170A1 System and method for liver cell culture and maturation
03/19/2009WO2009036095A1 Engineered light-harvesting organisms
03/19/2009WO2009035901A1 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system
03/19/2009WO2009035629A1 Method for modifying cellular immune response by modulating activin activity
03/19/2009WO2009035612A2 Multilineage-inducible cells and uses thereof
03/19/2009WO2009035217A1 Process for differentiation of vascular endothelial progenitor cells from embryoid bodies derived from embryonic stem cells using hypoxic media condition
03/19/2009WO2009034961A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent
03/19/2009WO2009034927A1 Cell culture instrument and cell culture method using the same
03/19/2009WO2009034708A1 Cell proliferation method, and pharmaceutical agent for repair and regeneration of tissue
03/19/2009WO2009034436A2 'hematopoietic cells that express tmcc-1'
03/19/2009WO2009034172A1 Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
03/19/2009WO2009034108A1 An in vitro beating heart model
03/19/2009WO2009033715A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
03/19/2009WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody
03/19/2009WO2009017655A3 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof
03/19/2009WO2009014340A3 Process for differentiating embryonic stem cells using porous membrane
03/19/2009WO2009008928A3 Methods for treating nervous system injury and disease
03/19/2009WO2009008666A3 Autologous dendritic cell mediated by photodynamic therapy having the ability to suppress the growth of tumor
03/19/2009WO2009007618A3 Tumour-cell-fixing cells
03/19/2009WO2009002456A3 Methods and compositions relating to progenitor cells
03/19/2009WO2008132485A3 Mutants of interleukin- 1 receptor antagonist and uses thereof
03/19/2009WO2008116157A3 Mesenchymal stem cells and uses therefor
03/19/2009WO2005079355A3 Use of indanoyl amide to stimulate secondary metabolism in taxus sp.
03/19/2009WO2005069987A3 Amplifying interfering rna (rnai) expression and effects
03/19/2009WO2005010162A3 Automated cell culture system and process
03/19/2009US20090077695 Interferon Produced In Plastids
03/19/2009US20090077694 Soybean transformation method
03/19/2009US20090077693 Methods of producing gaba
03/19/2009US20090077691 Root-Preferred Regulatory Elements
03/19/2009US20090077690 Defensin polynucleotides and methods of use
03/19/2009US20090077689 Defensin polynucleotides and methods of use
03/19/2009US20090077688 Crop plants with disease resistance against fungal pathogens such as Colletotrichum graminicola, Diplodia maydis, Fusarium graminearum, and Fusarium moniliforme, or nematodes
03/19/2009US20090077687 Nematode resistant transgenic plants
03/19/2009US20090077686 Modification of plant lignin content
03/19/2009US20090077681 Methods for Diagnosing and Treating Heart Disease
03/19/2009US20090077680 Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same
03/19/2009US20090077679 Gene silencing by systemic rna interference
03/19/2009US20090077678 Transgenic mollusk and method for producing the same
03/19/2009US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring
03/19/2009US20090076103 Stem cell differentiating agents and uses therefor
03/19/2009US20090076024 Episomal Fusion Gene
03/19/2009US20090075984 Materials and methods relating to protein aggregation in neurodegenerative disease
03/19/2009US20090075975 Arylsulfonamides and uses related thereto
03/19/2009US20090075948 Compositions and methods for regulating cellular protection
03/19/2009US20090075932 METHOD OF SELECTIVELY INHIBITING PKCiota
03/19/2009US20090075927 Sweet taste receptors
03/19/2009US20090075926 Method for identifying and manipulating cells
03/19/2009US20090075925 Methods and Compositions Related to APOBEC-1 Expression
03/19/2009US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring
03/19/2009US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist
03/19/2009US20090075900 Therapeutic agent for motor neuron disease
03/19/2009US20090075893 Inhibition of Angiogenesis by Neutrophil Alpha-Defensins
03/19/2009US20090075889 Iren protein, its preparation and use
03/19/2009US20090075888 Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta
03/19/2009US20090075886 Dendritic cell stimulatory factor
03/19/2009US20090075883 Compositions for the treatment of cancer, and methods for testing and using the same
03/19/2009US20090075882 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis
03/19/2009US20090075880 Albumin Fusion Proteins
03/19/2009US20090075877 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
03/19/2009US20090075876 Altered insulin-like growth factor binding proteins
03/19/2009US20090075871 Modified Thioredoxin
03/19/2009US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof
03/19/2009US20090075384 contain alphavirus 5' and alphavirus 3' replication recognition sequences and a nucleotide sequence encoding an alphavirus structural protein; alphavirus replicon particles useful as immunostimulants
03/19/2009US20090075382 Fibre-reinforced scaffold
03/19/2009US20090075381 Amnion-derived cell compositions, methods of making and uses thereof
03/19/2009US20090075380 Methods and Compositions To Enhance Efficiency Of Nuclear Transfer/Cloning
03/19/2009US20090075379 Modulation of homologous recombination with single stranded dna binding proteins
03/19/2009US20090075378 Somatic hypermutation systems
03/19/2009US20090075377 Molecular interactions in cells
03/19/2009US20090075375 Choroid plexus preparation and uses thereof
03/19/2009US20090075374 Methods of generating epithelial lineage cells from embryoid bodies and pluripotent cells
03/19/2009US20090075373 Neural progenitor cells derived from embryonic stem cells
03/19/2009US20090075372 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population
03/19/2009US20090075371 Regenerative Medicine Devices and Foam Methods of Manufacture
03/19/2009US20090075341 Il-21 antagonists
03/19/2009US20090075340 Kir-Binding Agents and Methods of Use Thereof
03/19/2009US20090075339 Autophilic antibodies
03/19/2009US20090075331 Industrial-scale serum-free production of recombinant proteins in mammalian cells
03/19/2009US20090075322 Method of analyzing various surface chemistries for culturing a given cell line
03/19/2009US20090075320 Method for screening an enhancer or a masker of salty taste
03/19/2009US20090075316 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
03/19/2009US20090075313 Split protein fragments, split protein systems, methods of making split protein systems, and methods of using split protein systems
03/19/2009US20090075297 Mammalian galanin receptors
03/19/2009US20090075277 Method for detecting ovarian cancer and method for suppressing the same
03/19/2009US20090075270 Products and Methods Relating to the Use of the Endoribonuclease Kid/PemK
03/19/2009US20090074884 Family of pfkfb3 inhibitors with anti-neoplastic activities
03/19/2009US20090074870 Alteration of cell membrane for new functions
03/19/2009US20090074852 Lipoplex formulations for specific delivery to vascular endothelium
03/19/2009US20090074835 Human disc tissue
03/19/2009US20090074832 Medical Scaffold, Methods of Fabrication and Using Thereof
03/19/2009US20090074813 Compositions And Methods Using Variant Tat Proteins
03/19/2009US20090074807 Moraxella (branhamella) catarrhalis antigens
03/19/2009US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8
03/19/2009US20090074793 High Affinity Human Antibodies to Human IL-4 Receptor
03/19/2009US20090074788 Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved
03/19/2009US20090074784 Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells
03/19/2009US20090074782 Compositions and Methods for Treating and Diagnosing Cancer
03/19/2009US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples
03/19/2009US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
03/19/2009US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 1827